AMENDMENT
TO
FORM 10-Q
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
(Mark One)
[X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended October 31, 1996
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from: ________________ to _______________
Commission file number: 0-5958
MERIDIAN MEDICAL TECHNOLOGIES, INC.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 52-0898764
- ------------------------------- --------------------
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
10240 Old Columbia Road, Columbia, Maryland 21046
- ------------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: 410-309-6830
Indicate by check mark whether the Registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
YES [X] NO [ ]
Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the latest practicable date.
Class Outstanding as of October 31, 1996
- ---------------------------- -----------------------------------
Common Stock, $.10 par value 3,097,953 Shares
<PAGE>
THE PURPOSE OF THIS FILING IS TO AMEND THE 1st QUARTER 10-Q FILED 12/96
BY ATTACHING THE FINANCIAL DATA SCHEDULE EXHIBIT 27
MERIDIAN MEDICAL TECHNOLOGIES, INC.
AMENDMENT
TO
FORM 10-Q
FOR THE QUARTER ENDED OCTOBER 31, 1996
ITEM 6. Exhibits and Reports on Form 8-K:
27. Financial Data Schedule
The following document is filed as part of this report:
Financial Data Schedule as Exhibit 27
contains summary financial information
extracted from the Consolidated Condensed
Balance Sheets and Statements of Income and
is qualified in its entirety by reference to
such financial statements.
<PAGE>
MERIDIAN MEDICAL TECHNOLOGIES, INC.
AMENDMENT
TO
FORM 10-Q
FOR THE QUARTER ENDED OCTOBER 31, 1996
SIGNATURES
Pursuant to the requirement of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
MERIDIAN MEDICAL TECHNOLOGIES, INC.
-----------------------------------
Registrant
May 27, 1997 By: /s/ James H. Miller
- -------------- -------------------------
Date James H. Miller
President and Chief Executive Officer
(Principal Executive Officer)
May 27, 1997 By: /s/ George Troy Braswell
- -------------- -------------------------
Date George Troy Braswell
Vice President and
Chief Financial Officer
(Principal Financial and
Accounting Officer)
WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
Consolidated Condensed Balance Sheets and Statement of Income
</LEGEND>
<MULTIPLIER> 1.0
<CURRENCY> U.S. Dollars
<S> <C>
<PERIOD-TYPE> 3-Mos
<FISCAL-YEAR-END> Jul-31-1997
<PERIOD-START> Aug-1-1996
<PERIOD-END> Oct-31-1996
<EXCHANGE-RATE> 1.000
<CASH> 270,000
<SECURITIES> 0
<RECEIVABLES> 4,732,600
<ALLOWANCES> 0
<INVENTORY> 4,431,200
<CURRENT-ASSETS> 11,848,200
<PP&E> 27,047,300
<DEPRECIATION> 12,167,600
<TOTAL-ASSETS> 28,542,100
<CURRENT-LIABILITIES> 6,932,200
<BONDS> 0
0
0
<COMMON> 309,800
<OTHER-SE> 17,859,900
<TOTAL-LIABILITY-AND-EQUITY> 28,542,100
<SALES> 9,256,500
<TOTAL-REVENUES> 9,256,500
<CGS> 5,931,600
<TOTAL-COSTS> 8,170,100
<OTHER-EXPENSES> (47,300)
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 60,400
<INCOME-PRETAX> 1,073,300
<INCOME-TAX> 415,000
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 658,300
<EPS-PRIMARY> (0.21)
<EPS-DILUTED> (0.21)
</TABLE>
